Medication adherence of diabetic and hypertensive patients attending primary health care centers: Cross-sectional study in Morocco

Factors associated with non-medication adherence

Authors

  • Samira Essoli Clinical Research Department, Mohammed VI University Hospital AND Department of Community Medicine and Public Health, Bioscience, Health, and Research Laboratory, School of Medicine, Cadi Ayyad University, Marrakesh, Morocco https://orcid.org/0000-0002-8368-4297
  • Latifa Adarmouch Clinical Research Department, Mohammed VI University Hospital AND Department of Community Medicine and Public Health, Bioscience, Health, and Research Laboratory, School of Medicine, Cadi Ayyad University, Marrakesh, Morocco https://orcid.org/0000-0002-9543-6899
  • Adil Mansouri Clinical Research Department, Mohammed VI University Hospital AND Department of Community Medicine and Public Health, Bioscience, Health, and Research Laboratory, School of Medicine, Cadi Ayyad University, Marrakesh, Morocco https://orcid.org/0000-0002-2192-3838
  • Sarah Michaud Clinical Research Department, Mohammed VI University Hospital AND Department of Community Medicine and Public Health, Bioscience, Health, and Research Laboratory, School of Medicine, Cadi Ayyad University, Marrakesh, Morocco https://orcid.org/0000-0002-7317-9174
  • Majda Sebbani Clinical Research Department, Mohammed VI University Hospital AND Department of Community Medicine and Public Health, Bioscience, Health, and Research Laboratory, School of Medicine, Cadi Ayyad University, Marrakesh, Morocco https://orcid.org/0000-0001-5827-1098
  • Mohamed Amine Clinical Research Department, Mohammed VI University Hospital AND Department of Community Medicine and Public Health, Bioscience, Health, and Research Laboratory, School of Medicine, Cadi Ayyad University, Marrakesh, Morocco https://orcid.org/0000-0002-9008-277X

DOI:

https://doi.org/10.22122/cdj.v13i1.748

Keywords:

Medication Adherence, Chronic Diseases, Diabetes Mellitus, Hypertension, Morocco

Abstract

BACKGROUND: Medication adherence is a key factor in controlling chronic diseases, particularly diabetes and high blood pressure. We aimed to describe the level of medication adherence of patients with diabetes or high blood pressure in urban and rural areas in Morocco and to identify the factors associated with medication
non-adherence.

METHODS: A cross-sectional study was conducted from August 1, 2019 to January 30, 2020, among participants recruited from primary health centers in Morocco. The Girard questionnaire was used to measure medication adherence, and bivariate and multivariate analyses were done using SPSS software.

RESULTS: A total of 502 patients were recruited with a majority of women (70.5%). According to the Girard questionnaire, a minority of our patients had a good adherence to medication (11.8%), less than half had a low adherence (38.4%), and half were non-adherent (50%). The factors associated with medication non-adherence for patients with diabetes were: living in rural areas, being overweight, taking antidiabetic oral drugs, and suffering from dyslipidemia. Concerning the patients with high blood pressure, medication non-adherence was higher among patients with dyslipidemia, overweight patients, and those who benefited from a free treatment. For patients suffering from both, the associated factors of non-adherence were taking oral drugs, a multi-therapy of anti-hypertensive drugs, and shorter diabetes duration.

CONCLUSION: This study highlighted several matters concerning medication adherence among patients with chronic diseases. Healthcare professionals should encourage and help their patients to take their medications.

References

National Agency for Statistics and Demography. National Survey on Risk Factors for Noncommunicable Diseases (2015). Senegal: National Agency for Statistics and Demography; 2016 [Online]. [cited 2016 Dec 02]; Avilable from: URL: https://anads.ansd.sn/index.php/catalog/127. [In French].

Jüngst C, Gräber S, Simons S, Wedemeyer H, Lammert F. Medication adherence among patients with chronic diseases: a survey-based study in pharmacies. Qjm. 2019; 112(7): 505-12.

Raghupathi W, Raghupathi V. An Empirical Study of Chronic Diseases in the United States: A Visual Analytics Approach. Int J Environ Res Public Health. 2018; 15(3): 431.

Scheen AJ, Giet D. [Non compliance to medical therapy; causes, consequences, solutions]. Rev Med Liege. 2010; 65(5-6): 239-45.

Yuvaraj K, Gokul S, Sivaranjini K, Manikandanesan S, Murali S, Surendran G, et al. Prevalence of medication adherence and its associated factors among patients with noncommunicable disease in rural Puducherry, South India - A facility-based cross-sectional study. J Family Med Prim Care. 2019; 8(2): 701-5.

Khouri Y, Steigerwalt SP, Alsamara M, McCullough PA. What is the ideal blood pressure goal for patients with stage III or higher chronic kidney disease? Curr Cardiol Rep. 2011; 13(6): 492-501.

Naour O, Benmalek R, Nouamou I, Zahidi H, Benouna E, Habbal R. Evaluation of Therapeutic Adherence among Moroccan Hypertensive Patients: About 1482 Cases. Jour Clin Med Res. 2020; 01(2): 1-9.

El Aassri H, El Mghari G, El Ansari N. [Type 2 diabetic patients with hypertension: do they prefer treating diabetes or hypertension?]. Pan Afr Med J. 2014; 17: 193.

Genuth SM, Palmer JP, Nathan DM. Classification and Diagnosis of Diabetes. In: Cowie CC, Casagrande SS, Menke A, Cissell MA, Eberhardt MS, Meigs JB, et al., editors. Diabetes in America. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (US); 2018.

Gelfer M, Dawes M, Kaczorowski J, Padwal R, Cloutier L. Diagnosing hypertension: Evidence supporting the 2015 recommendations of the Canadian Hypertension Education Program. Can Fam Physician. 2015; 61(11): 957-61.

Anon. Poor adherence to long-term treatment of chronic diseases is a worldwide problem. 2003. Rev Panam Salud Publica. 2003; 14(3): 218-21.

Ntyonga-Pono MP. Adherence to antidiabetic therapy in diabetic patients in Gabon: Preliminary data. Médecine des Maladies Métaboliques. 2015; 9(2): 198-202. [In French].

Girerd X, Hanon O, Anagnostopoulos K, Ciupek C, Mourad J, Consoli S. Evaluation de l'observance du traitement antihypertenseur par un questionnaire: mise au point et utilisation dans un service spécialisé. Presse Med (1893). 2001; 30(21): 1044-8.

Armstrong T, Bull F. Development of the world health organization global physical activity questionnaire (GPAQ). J Public Health. 2006; 14: 66-70.

Basu S, Garg S, Sharma N, Singh MM. Improving the assessment of medication adherence: Challenges and considerations with a focus on low-resource settings. Tzu Chi Med J. 2019; 31(2): 73-80.

Wanvoegbe F, Agbodande K, Alassani A, Aviansou A, Gninkoun J, Amoussou-Guenou D, et al. Evaluation de l'observance thérapeutique chez les diabétiques au Bénin. Med Afr noire (En ligne). 2018: 355-61.

Bchir MS, Kechida M, Klii R, Hammami S, Khochtali I. Observance thérapeutique et estime de soi au cours des maladies chroniques: y’a-t-il une corrélation? Rev Med Interne. 2018; 39: A243-A4.

Alqarni AM, Alrahbeni T, Qarni AA, Qarni HMA. Adherence to diabetes medication among diabetic patients in the Bisha governorate of Saudi Arabia - a cross-sectional survey. Patient Prefer Adherence. 2019; 13: 63-71.

Pio M, Baragou S, Afassinou Y, Pessinaba S, Atta B, Ehlan K, et al. Observance thérapeutique de l’hypertension artérielle et ses facteurs dans le service de cardiologie du CHU Tokoin de Lomé. Pan Afr Med J. 2013; 14(1): 48.

Konin C, Adoh MA, Coulibaly IM, Kramoh E, Safou M, N’guetta R, et al. L'observance thérapeutique et ses facteurs chez l'hypertendu noir africain. Arch Mal Coeur Vaiss. 2007; 100(8): 630-4.

Essomba NE, Hamadou B, Koum DCK, Atemkeng A, Coppieters Y. Facteurs de Non Observance au Traitement Anti Hypertenseur chez les Adultes à Douala. Health Sci Dis. 2017; 18(3).

Yassine M, Al-Hajje A, Awada S, Rachidi S, Zein S, Bawab W, et al. Evaluation of medication adherence in Lebanese hypertensive patients. J Epidemiol Glob Health. 2016; 6(3): 157-67.

Rahmawati R, Bajorek B. Factors affecting self-reported medication adherence and hypertension knowledge: A cross-sectional study in rural villages, Yogyakarta Province, Indonesia. Chronic Illn. 2018; 14(3): 212-27.

Mariye T, Girmay A, Birhanu T, Tasew H, Teklay G, Baraki Z, et al. Adherence to insulin therapy and associated factors among patients with diabetes mellitus in public hospitals of Central Zone of Tigray, Ethiopia, 2018: a cross-sectional study. Pan Afr Med J. 2019; 33: 309.

Ayoub D, Mroueh L, El-Hajj M, Awada S, Rachidi S, Zein S, et al. Evaluation of antidiabetic medication adherence in the Lebanese population: development of the Lebanese Diabetes Medication Adherence Scale. Int J Pharm Pract. 2019; 27(5): 468-76.

Napolitano F, Napolitano P, Angelillo IF, Group CW. Medication adherence among patients with chronic conditions in Italy. Eur J Public Health. 2016; 26(1): 48-52.

Stroebe M, Schut H, Boerner K. Cautioning Health-Care Professionals. Omega (Westport). 2017; 74(4): 455-73.

Kassavou A, Houghton V, Edwards S, Brimicombe J, Wilson E, Griffin S, et al. Acceptability of the Medication Adherence for Patients Support intervention to improve adherence to patients prescribed medications for hypertension or comorbidities, as an adjunct to primary care: A qualitative study. J Health Psychol. 2021; 26(1): 168-80.

Tam HL, Wong EML, Cheung K. Effectiveness of Educational Interventions on Adherence to Lifestyle Modifications Among Hypertensive Patients: An Integrative Review. Int J Environ Res Public Health. 2020; 17(7): 2513.

Downloads

Published

2025-02-12

How to Cite

1.
Essoli S, Adarmouch L, Mansouri A, Michaud S, Sebbani M, Amine M. Medication adherence of diabetic and hypertensive patients attending primary health care centers: Cross-sectional study in Morocco: Factors associated with non-medication adherence. Chron Dis J. 2025;13(1):49–56.

Issue

Vol 13, No 1 (2025) (Incomplete Issue)

Section

Original Article(s)

License

Copyright (c) 2025 Chronic Diseases Journal

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.